Comparison of adverse drug reactions of statins in China from 1989 to 2019

Eur J Hosp Pharm. 2023 Aug 4:ejhpharm-2023-003929. doi: 10.1136/ejhpharm-2023-003929. Online ahead of print.

Authors

Leo Tsui¹, Wei-Jie Liang²

Affiliations

¹ School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, Shanghai, China standhavemail@yahoo.com.tw.
² School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.

PMID: 37541777
DOI: 10.1136/ejhpharm-2023-003929

No abstract available

Keywords: CLINICAL MEDICINE; Clinical Trial; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; Lipid Metabolism Disorders; Safety.

Publication types

Letter